Rocket sells PRV for $180M: The New Jersey gene therapy maker sold the rare pediatric disease priority review voucher to an undisclosed buyer. Rocket Pharmaceuticals got the PRV after securing FDA …
UK study finds clue to rising cancer rates in younger people
A study has found evidence that 11 cancers are becoming more common among young people in England, and points to a main driving factor.

